The comparison of the curative effect on benign prostatic hyperplasia between tamsulosin and naftopidil
Not Applicable
Recruiting
- Conditions
- benign prostatic hyperplasia
- Registration Number
- JPRN-UMIN000007763
- Lead Sponsor
- Tokyo Medical University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Male
- Target Recruitment
- 60
Inclusion Criteria
Not provided
Exclusion Criteria
Active prostate cancer or history The present illness which affect urinary condision The history of the treatment with alfa 1 blocker and/or anticholinergic drug within 4 weeks The history of the treatment with 5 alfa reductase inhibitor on benign prostatic hyperplasia The history of the surgical treatment which affect urinary condition The contraindication of alfa 1 blocker The case which the chief urologist desides not adequate for the examination
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method International Prostate Symptom Score Urinary flow rate Residual urine
- Secondary Outcome Measures
Name Time Method